These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 2933146)
41. PFK inhibition test for cancer detection: clinical applications and mechanisms of PFK inhibition. Nakamura K; Kituta T; Nakamura Y; Nakajima Y; Kobayashi K; Uchida T Cancer Detect Prev; 1987; 10(1-2):37-55. PubMed ID: 2952272 [TBL] [Abstract][Full Text] [Related]
42. Suppression of glucose utilization of murine peritoneal exudate macrophages by body fluids from cancer patients and identification of the susceptible enzyme. Nakamura K; Nakajima Y; Nakamura Y J Natl Cancer Inst; 1986 Nov; 77(5):1035-8. PubMed ID: 2945958 [TBL] [Abstract][Full Text] [Related]
43. Decrease of serum buffering capacity associated with malignant neoplasms. Nakamura K; Nakajima Y; Nakamura Y; Ogiwara H; Koide A Cancer Detect Prev; 1988; 13(3-4):175-87. PubMed ID: 2977297 [TBL] [Abstract][Full Text] [Related]
44. Characterization of two similar differential tumor markers based on phosphofructokinase activity arising from the influence of cancer patient serum. Nakamura K; Nakajima Y; Nakamura Y Cancer Detect Prev; 1988; 13(3-4):239-50. PubMed ID: 2977298 [TBL] [Abstract][Full Text] [Related]
45. A new cancer marker: a possible cancer screening method based on the suppression of phosphofructokinase by sera from cancer patients. Nakamura K; Kituta T; Takahashi T; Nakamura Y; Nakajima Y Cancer Detect Prev; 1985; 8(1-2):207-18. PubMed ID: 2933146 [TBL] [Abstract][Full Text] [Related]
46. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism. Vestergaard H Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651 [TBL] [Abstract][Full Text] [Related]